4-((R)-2-Hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino)butyl 3-Methoxy-4-((3-((S)-phenyl(((R)-quinuclidin-3-yloxy)carbonylamino)methyl)phenoxy)methyl)benzoate

ID: ALA5200887

Chembl Id: CHEMBL5200887

PubChem CID: 168290830

Max Phase: Preclinical

Molecular Formula: C45H50N4O9

Molecular Weight: 790.91

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)OCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1COc1cccc([C@@H](NC(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1

Standard InChI:  InChI=1S/C45H50N4O9/c1-55-39-25-32(44(53)56-23-6-5-20-46-26-38(51)35-14-16-37(50)43-36(35)15-17-41(52)47-43)12-13-33(39)28-57-34-11-7-10-31(24-34)42(30-8-3-2-4-9-30)48-45(54)58-40-27-49-21-18-29(40)19-22-49/h2-4,7-17,24-25,29,38,40,42,46,50-51H,5-6,18-23,26-28H2,1H3,(H,47,52)(H,48,54)/t38-,40-,42-/m0/s1

Standard InChI Key:  OANLKDACTIRKTE-HITUISKBSA-N

Alternative Forms

  1. Parent:

    ALA5200887

    ---

Associated Targets(Human)

CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

GPM3 Muscarinic acetylcholine receptor M3 (1154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trachea (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adrb2 Beta-2 adrenergic receptor (1382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 790.91Molecular Weight (Monoisotopic): 790.3578AlogP: 5.99#Rotatable Bonds: 17
Polar Surface Area: 171.68Molecular Species: BASEHBA: 11HBD: 5
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 3
CX Acidic pKa: 8.39CX Basic pKa: 9.81CX LogP: 4.47CX LogD: 2.20
Aromatic Rings: 5Heavy Atoms: 58QED Weighted: 0.06Np Likeness Score: -0.14

References

1. Carzaniga L, Linney ID, Rizzi A, Delcanale M, Schmidt W, Knight CK, Pastore F, Miglietta D, Carnini C, Cesari N, Riccardi B, Mileo V, Venturi L, Moretti E, Blackaby WP, Patacchini R, Accetta A, Biagetti M, Bassani F, Tondelli M, Murgo A, Battipaglia L, Villetti G, Puccini P, Catinella S, Civelli M, Rancati F..  (2022)  Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.,  65  (15.0): [PMID:35901125] [10.1021/acs.jmedchem.2c00609]

Source